Cargando…

Peptides for Therapy and Diagnosis of Alzheimer’s Disease

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder with devastating effects. The greatest risk factor to develop AD is age. Today, only symptomatic therapies are available. Additionally, AD can be diagnosed with certainty only post mortem, whereas the diagnosis “probable AD” can be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Funke, Susanne Aileen, Willbold, Dieter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426787/ https://www.ncbi.nlm.nih.gov/pubmed/22236121 http://dx.doi.org/10.2174/138161212799277752

Ejemplares similares

Selection and Characterization of Tau Binding ᴅ-Enantiomeric Peptides with Potential for Therapy of Alzheimer Disease
por: Dammers, Christina, et al.
Publicado: (2016)

Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease
por: Aillaud, Isabelle, et al.
Publicado: (2022)

Detection of Soluble Amyloid-β Oligomers and Insoluble High-Molecular-Weight Particles in CSF: Development of Methods with Potential for Diagnosis and Therapy Monitoring of Alzheimer's Disease
por: Funke, Susanne Aileen
Publicado: (2011)

The D-amino acid peptide D3 reduces amyloid fibril boosted HIV-1 infectivity
por: Widera, Marek, et al.
Publicado: (2014)

A Survey of Peptides with Effective Therapeutic Potential in Alzheimer’s Disease Rodent Models or in Human Clinical Studies
por: Sun, N, et al.
Publicado: (2012)

Development of a Small D-Enantiomeric Alzheimer’s Amyloid-β Binding Peptide Ligand for Future In Vivo Imaging Applications
por: Funke, Susanne Aileen, et al.
Publicado: (2012)

Characterization of a Single-Chain Variable Fragment Recognizing a Linear Epitope of Aβ: A Biotechnical Tool for Studies on Alzheimer’s Disease?
por: Dornieden, Silke, et al.
Publicado: (2013)

Tailoring the Antibody Response to Aggregated Aß Using Novel Alzheimer-Vaccines
por: Mandler, Markus, et al.
Publicado: (2015)

Competitive Mirror Image Phage Display Derived Peptide Modulates Amyloid Beta Aggregation and Toxicity
por: Rudolph, Stephan, et al.
Publicado: (2016)

Correction: Competitive Mirror Image Phage Display Derived Peptide Modulates Amyloid Beta Aggregation and Toxicity
por: Rudolph, Stephan, et al.
Publicado: (2016)

Optimization of the All-D Peptide D3 for Aβ Oligomer Elimination
por: Klein, Antonia Nicole, et al.
Publicado: (2016)

Do We Need Anti-Prionic Compounds to Treat Alzheimer’s Disease?
por: Willbold, Dieter, et al.
Publicado: (2019)

In Vitro and In Vivo Efficacies of the Linear and the Cyclic Version of an All-d-Enantiomeric Peptide Developed for the Treatment of Alzheimer’s Disease
por: Schemmert, Sarah, et al.
Publicado: (2021)

Phage display derived peptides for Alzheimer's disease therapy and diagnosis
por: Zhang, Xiancheng, et al.
Publicado: (2022)

Stabilization of Monomeric Tau Protein by All D-Enantiomeric Peptide Ligands as Therapeutic Strategy for Alzheimer’s Disease and Other Tauopathies
por: Altendorf, Tim, et al.
Publicado: (2023)

In Vitro Potency and Preclinical Pharmacokinetic Comparison of All-D-Enantiomeric Peptides Developed for the Treatment of Alzheimer’s Disease
por: Schartmann, Elena, et al.
Publicado: (2018)

Inhibition of Polyglutamine Misfolding with D-Enantiomeric Peptides Identified by Mirror Image Phage Display Selection
por: Kolkwitz, Pauline Elisabeth, et al.
Publicado: (2022)

Preclinical Pharmacokinetic Studies of the Tritium Labelled D-Enantiomeric Peptide D3 Developed for the Treatment of Alzheimer´s Disease
por: Jiang, Nan, et al.
Publicado: (2015)

Use of Peptides for the Management of Alzheimer’s Disease: Diagnosis and Inhibition
por: Baig, Mohammad H., et al.
Publicado: (2018)

Monomeric Amyloid Beta Peptide in Hexafluoroisopropanol Detected by Small Angle Neutron Scattering
por: Zhang-Haagen, Bo, et al.
Publicado: (2016)

Antimicrobial Peptides (AMPs) in the Pathogenesis of Alzheimer’s Disease: Implications for Diagnosis and Treatment
por: Bruno, Francesco, et al.
Publicado: (2022)

Oral treatment with the all-d-peptide RD2 enhances cognition in aged beagle dogs – A model of sporadic Alzheimer’s disease
por: Kutzsche, Janine, et al.
Publicado: (2023)

Development and Implementation of an Internal Quality Control Sample to Standardize Oligomer-Based Diagnostics of Alzheimer’s Disease
por: Pils, Marlene, et al.
Publicado: (2023)

A Novel Anti-Inflammatory d-Peptide Inhibits Disease Phenotype Progression in an ALS Mouse Model
por: Post, Julia, et al.
Publicado: (2021)

Recent Advances in the Application Peptide and Peptoid in Diagnosis Biomarkers of Alzheimer’s Disease in Blood
por: Guo, Yuxin, et al.
Publicado: (2021)

Large-Scale Oral Treatment Study with the Four Most Promising D3-Derivatives for the Treatment of Alzheimer’s Disease
por: Kutzsche, Janine, et al.
Publicado: (2017)

A Computer-Aided Approach for the Discovery of D-Peptides as Inhibitors of SARS-CoV-2 Main Protease
por: Hernández González, Jorge E., et al.
Publicado: (2022)

PEAβ Triggers Cognitive Decline and Amyloid Burden in a Novel Mouse Model of Alzheimer’s Disease
por: Camargo, Luana Cristina, et al.
Publicado: (2021)

The plasma peptides of Alzheimer’s disease
por: Florentinus-Mefailoski, Angelique, et al.
Publicado: (2021)

Advances in Alzheimer’s Disease-Associated Aβ Therapy Based on Peptide
por: Wang, Cunli, et al.
Publicado: (2023)

Selecting Multitarget Peptides for Alzheimer’s Disease
por: Kasus-Jacobi, Anne, et al.
Publicado: (2022)

Corrigendum: Recent Advances in the Application Peptide and Peptoid in Diagnosis Biomarkers of Alzheimer's Disease in Blood
por: Guo, Yuxin, et al.
Publicado: (2022)

Aluminum-Induced Amyloidogenesis and Impairment in the Clearance of Amyloid Peptides from the Central Nervous System in Alzheimer’s Disease
por: Zhao, Yuhai, et al.
Publicado: (2014)

Nanoscale Extracellular Vesicle Analysis in Alzheimer's Disease Diagnosis and Therapy
por: Heinzelman, Pete, et al.
Publicado: (2016)

Synthesis of Peptide Radiopharmaceuticals for the Therapy and Diagnosis of Tumor Diseases
por: Jamous, Mazen, et al.
Publicado: (2013)

A novel D-amino acid peptide with therapeutic potential (ISAD1) inhibits aggregation of neurotoxic disease-relevant mutant Tau and prevents Tau toxicity in vitro
por: Aillaud, Isabelle, et al.
Publicado: (2022)

Structure determination of human Lck unique and SH3 domains by nuclear magnetic resonance spectroscopy
por: Briese, Lars, et al.
Publicado: (2003)

Kinetic Titration Series with Biolayer Interferometry
por: Frenzel, Daniel, et al.
Publicado: (2014)

Peptides as Potential Therapeutics for Alzheimer’s Disease
por: Ribarič, Samo
Publicado: (2018)

Potent Tau Aggregation Inhibitor D‐Peptides Selected against Tau‐Repeat 2 Using Mirror Image Phage Display
por: Malhis, Marwa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n5cg64jrlv8hgg3qlm5bb407dn